Extended Data Fig. 10: The IL-33–ILC2–TLS pathway.
From: IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer
Proposed schematic of IL-33–ILC2–TLS pathway. TLS: tertiary lymphoid structure. © 2024 Memorial Sloan-Kettering Cancer Center, Memorial Hospital for Cancer and Allied Diseases, and Sloan-Kettering Institute for Cancer Research, each in New York, NY. All rights reserved. Republished with permission.
